Natalizumab Treatment for Relapsing Multiple Sclerosis Stabilises Normal-Appearing White Matter Microstructure: A One-Year Prospective Ultra-High-Field Quantitative Imaging Study
<h3>Background</h3><p dir="ltr">Natalizumab dramatically reduces relapses and MRI inflammatory activity (new lesions and enhancing lesions) in multiple sclerosis (MS). Chemical exchange saturation transfer (CEST) MRI can explore brain tissue in vivo with high resolution a...
محفوظ في:
| المؤلف الرئيسي: | Radu Tanasescu (439168) (author) |
|---|---|
| مؤلفون آخرون: | Olivier Mougin (17541336) (author), I-Jun Chou (671330) (author), Ali Al-Radaideh (17930141) (author), Oltita P. Jerca (17541342) (author), Su-Yin Lim (17109253) (author), Penny Gowland (615649) (author), Cris S. Constantinescu (10649157) (author) |
| منشور في: |
2023
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
Management of Baló Concentric Sclerosis with rituximab: A case study with long-term follow-up
حسب: Lina Okar (14777164)
منشور في: (2023) -
From prevention to management: Exploring the impact of diet on multiple sclerosis
حسب: Dalya Koukach (22466848)
منشور في: (2025) -
A Potential Link Between Oxidative Stress and Endothelial-to-Mesenchymal Transition in Systemic Sclerosis
حسب: Duong Thi Bich Thuan (18069361)
منشور في: (2018) -
Electroencephalographic evidence of gray matter lesions among multiple sclerosis patients A case-control study
حسب: Ahmed Abduljawad Salim (16328642)
منشور في: (2021) -
The Potential Role of COVID-19 in the Pathogenesis of Multiple Sclerosis—A Preliminary Report
حسب: Noothan Satheesh (18595729)
منشور في: (2021)